These observations indicated that mean percent methylation of the ASNS gene evaluated with the HPLC method is a useful pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL specimens. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.